Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

3M hikes first-quarter earnings forecast amid healthcare unit spin-off

Published 03/13/2024, 09:02 PM
Updated 03/13/2024, 09:02 PM
© Reuters.

3M Co. (NYSE:MMM) has revised its earnings forecast for the first quarter, raising its per-share earnings expectation to up to $2.20 from a previous range of $2 to $2.15.

The company’s shares rose 1% ahead of Wednesday’s market open.

This hike is attributed to the impact of interest from a debt transaction related to the spinoff of 3M’s Solventum healthcare division, as explained by CEO Mike Roman during a JPMorgan industrials conference.

The unit is scheduled to become an independent entity on April 1.

On Tuesday, announced it has chosen Bill Brown, previously the chief executive at L3Harris Technologies, as its new CEO

This decision shows that the industrial corporation is betting on an external leader to help the company navigate a difficult period marked by declining sales and numerous legal challenges.

Following the announcement, the company's stock saw a nearly 7% surge on Tuesday.

Year-to-date, MMM shares have fallen roughly 10% as the company faced multi-billion dollar lawsuits concerning its earplugs and the environmental impact of its "forever chemicals," alongside diminishing demand.

Bill Brown, aged 61, is set to replace Michael Roman as CEO starting May 1. Roman, who has dedicated 35 years to 3M, will transition to the role of executive chairman of the board concurrently.

During Wednesday’s conference, Roman highlighted that the company is advancing in resolving the litigation.

He mentioned that out of nearly 300,000 plaintiffs involved in the earplug lawsuit, fewer than 25 have chosen not to participate in the settlement. Similarly, there's a mid-single digit percentage of opt-outs observed in the settlement process concerning the drinking water utility issue.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.